Results
1 -
10 of
32
(Click
here to explore results)
New polyethyleneglycol-functionalized texaphyrins: synthesis and in vitro biological studies . Wen-Hao Wei, Zhong Wang, Toshihisa Mizuno, Cecilia Cortez, Lei Fu, Mint Sirisawad, Louie Naumovski, Darren Magda, Jonathan L. Sessler
, Dalton Trans.
, 2006
, 1934
Gadolinium texaphyrin–methotrexate conjugates. Towards improved cancer chemotherapeutic agents . Wen-Hao Wei, Mark Fountain, Darren Magda, Zhong Wang, Phil Lecane, Mimi Mesfin, Dale Miles, Jonathan L. Sessler
, Org. Biomol. Chem.
, 2005
, 3
, 3290
Gadolinium texaphyrin (Gd-Tex)-malonato-platinum conjugates: Synthesis and comparison with carboplatin in normal and Pt-resistant cell lines . Jonathan F. Arambula, Jonathan L. Sessler, Mark E. Fountain, Wen-hao Wei, Darren Magda, Zahid H. Siddik
, Dalton Trans.
, 2009
, 10834
Motexafin gadolinium reacts with ascorbate to produce reactive oxygen species . Darren Magda, Nikolay Gerasimchuk, Philip Lecane, Richard A. Miller, John E. Biaglow, Jonathan L. Sessler
, Chem. Commun.
, 2002
, 2730
The first water coordination sphere of lanthanide(iii ) motexafins (Ln-Motex2+ , Ln = La, Gd, Lu) and its effects on structures, reduction potentials and UV-vis absorption spectra. Theoretical studies . Xiaoyan Cao, Norah Heinz, Jun Zhang, Michael Dolg
, Phys. Chem. Chem. Phys.
, 2017
, 19
, 20160
Hypoxia-targeted drug delivery . Amit Sharma, Jonathan F. Arambula, Seyoung Koo, Rajesh Kumar, Hardev Singh, Jonathan L. Sessler, Jong Seung Kim
, Chem. Soc. Rev.
, 2019
, 48
, 771
Fluorogenic reaction-based prodrug conjugates as targeted cancer theranostics . Min Hee Lee, Amit Sharma, Min Jung Chang, Jinju Lee, Subin Son, Jonathan L. Sessler, Chulhun Kang, Jong Seung Kim
, Chem. Soc. Rev.
, 2018
, 47
, 28
The therapeutic application of lanthanides . Simon P. Fricker
, Chem. Soc. Rev.
, 2006
, 35
, 524
Gadolinium-based nanoscale MRI contrast agents for tumor imaging . Yi Cao, Lijun Xu, Ye Kuang, Dangsheng Xiong, Renjun Pei
, J. Mater. Chem. B
, 2017
, 5
, 3431
A texaphyrin –oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells . Jonathan F. Arambula, Jonathan L. Sessler, Zahid H. Siddik
, Med. Chem. Commun.
, 2012
, 3
, 1275